查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1380291

單核細胞活化測試市場：按產品、來源、應用和最終用戶 - 2023-2030 年全球預測

Monocyte Activation Tests Market by Product (Monocyte Activation Test Kits, Reagents), Source (Cell Line-based, PBMC-based), Application, End-user - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

單核細胞活化測試市場預計將從 2022 年的 5.5143 億美元增加到 2030 年的 8.4146 億美元，預測期內年複合成長率為 5.42%。

單核細胞活化測試的全球市場

主要市場統計
市場金額：基準年 [2022] 55143萬美元
預計市場金額[2023] 58882萬美元
預計市場金額[2030] 84146萬美元
年複合成長率（%） 5.42%
單核細胞活化測試Market-IMG1

FPNV定位矩陣

FPNV 定位矩陣是評估單核細胞活化測試市場的重要工具。透過分析與業務策略和產品滿意度相關的關鍵指標來全面評估供應商。這使得使用者能夠根據自己的具體資訊做出明智的決策。進階分析將供應商分為四個像限，每個象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。洞察力使決策者能夠充滿信心地駕馭市場。

市場佔有率分析

市場佔有率分析為供應商的市場形勢提供了寶貴的見解。評估對整體收益、客戶群和其他關鍵指標的影響可以全面了解公司的業績及其面臨的競爭環境。該分析還揭示了研究期間的競爭水平，例如市場佔有率成長、碎片化、主導地位和行業整合。

該報告對以下幾個方面提供了寶貴的見解：

1.市場滲透：提供有關市場動態和主要企業產品的全面資訊。

2. 市場開拓：詳細分析新興和成熟細分市場的滲透情況，以突顯利潤豐厚的商機。

3. 市場多元化：有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：對未來技術、研發活動和突破性產品開發的智慧型洞察。

本報告解決了以下關鍵問題：

1.單核細胞活化測試市場的市場規模和預測是多少？

2. 單核細胞活化測試市場中哪些產品、細分市場、應用和領域具有最高的投資潛力？

3.單核細胞活化測試市場的競爭策略架構是怎樣的？

4.單核細胞活化測試市場的最新技術趨勢和法規結構是什麼？

5.單核細胞活化檢測市場主要廠商的市場佔有率是多少？

6. 進入單核細胞活化檢測市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 病人安全越來越重要，需要更安全、更可靠的熱原檢測
      • 擴大基於動物的體外替代療法的配合措施
      • 私營和公共部門增加對製藥業的投資
    • 抑制因素
      • 集中細胞活化檢測試劑盒和試劑的資本密集開發流程
    • 機會
      • 推出新開發的單核細胞活化檢測試劑盒
      • 增加每個國家的醫療基礎設施和支出
    • 任務
      • 與單核細胞活化檢測試劑盒和試劑的核准相關的嚴格法規障礙
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 核細胞活化測試市場：依產品

  • 介紹
  • 單核細胞活化檢測試劑盒
  • 試劑

第7章 核細胞活化測試市場：依來源分類

  • 介紹
  • 基於細胞株
  • PBMC基礎

第8章 活化測試市場：依應用分類

  • 介紹
  • 藥物開發
  • 醫療設備檢驗
  • 疫苗開發

第9章 活化測試市場：依最終用戶分類

  • 介紹
  • 生技公司
  • 醫療設備製造商
  • 藥品製造商

第10章 美洲單核細胞活化測試市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太單核細胞活化測試市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲單核細胞活化測試市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Becton, Dickinson and Company
    • CellMade Laboratories
    • Charles River Laboratories International, Inc
    • Eurofins Scientific SE
    • GenScript Biotech Corporation
    • Lonza Group Ltd.
    • Lps-Biosciences
    • 單核細胞活化測試 BioTech BV
    • Merck KGaA
    • Microcoat Biotechnologie GmbH
    • Nelson Laboratories, LLC by Sotera Health Company
    • SOLVIAS AG
    • Thermo Fisher Scientific Inc.
    • Wickham Micro Limited
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-69324464D094

The Monocyte Activation Tests Market is projected to reach USD 841.46 million by 2030 from USD 551.43 million in 2022, at a CAGR of 5.42% during the forecast period.

Global Monocyte Activation Tests Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 551.43 million
Estimated Year Value [2023] USD 588.82 million
Forecast Year Value [2030] USD 841.46 million
CAGR (%) 5.42%
Monocyte Activation Tests Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Monocyte Activation Tests Market.

Based on Product, market is studied across Monocyte Activation Test Kits and Reagents. The Reagents is projected to witness significant market share during forecast period.

Based on Source, market is studied across Cell Line-based and PBMC-based. The PBMC-based is projected to witness significant market share during forecast period.

Based on Application, market is studied across Drug Development, Medical devices Testing, and Vaccine Development. The Vaccine Development is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Biotechnology Companies, Medical Device Manufacturers, and Pharmaceutical Manufacturers. The Pharmaceutical Manufacturers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Monocyte Activation Tests Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Monocyte Activation Tests Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Monocyte Activation Tests Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, CellMade Laboratories, Charles River Laboratories International, Inc, Eurofins Scientific SE, GenScript Biotech Corporation, Lonza Group Ltd., Lps-Biosciences, MAT BioTech BV, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories, LLC by Sotera Health Company, SOLVIAS AG, Thermo Fisher Scientific Inc., and Wickham Micro Limited.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Monocyte Activation Tests Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Monocyte Activation Tests Market?

3. What is the competitive strategic window for identifying opportunities in the Monocyte Activation Tests Market?

4. What are the latest technology trends and regulatory frameworks in the Monocyte Activation Tests Market?

5. What is the market share of the leading vendors in the Monocyte Activation Tests Market?

6. Which modes and strategic moves are suitable for entering the Monocyte Activation Tests Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Monocyte Activation Tests Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising emphasis on patient safety and demand for safe and more reliable pyrogen testing
      • 5.1.1.2. Growing initiatives for animal-based in-vitro alternatives
      • 5.1.1.3. Increasing investments in the pharmaceutical sector by private and public sectors
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive development process of MAT kits and reagents
    • 5.1.3. Opportunities
      • 5.1.3.1. Launch of newly developed monocyte activation test kits
      • 5.1.3.2. Rising healthcare infrastructure and spending across economies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory hurdles associated with approval of MAT kits and reagents
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Monocyte Activation Tests Market, by Product

  • 6.1. Introduction
  • 6.2. Monocyte Activation Test Kits
  • 6.3. Reagents

7. Monocyte Activation Tests Market, by Source

  • 7.1. Introduction
  • 7.2. Cell Line-based
  • 7.3. PBMC-based

8. Monocyte Activation Tests Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Development
  • 8.3. Medical devices Testing
  • 8.4. Vaccine Development

9. Monocyte Activation Tests Market, by End-user

  • 9.1. Introduction
  • 9.2. Biotechnology Companies
  • 9.3. Medical Device Manufacturers
  • 9.4. Pharmaceutical Manufacturers

10. Americas Monocyte Activation Tests Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Monocyte Activation Tests Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Monocyte Activation Tests Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Becton, Dickinson and Company
    • 14.1.2. CellMade Laboratories
    • 14.1.3. Charles River Laboratories International, Inc
    • 14.1.4. Eurofins Scientific SE
    • 14.1.5. GenScript Biotech Corporation
    • 14.1.6. Lonza Group Ltd.
    • 14.1.7. Lps-Biosciences
    • 14.1.8. MAT BioTech BV
    • 14.1.9. Merck KGaA
    • 14.1.10. Microcoat Biotechnologie GmbH
    • 14.1.11. Nelson Laboratories, LLC by Sotera Health Company
    • 14.1.12. SOLVIAS AG
    • 14.1.13. Thermo Fisher Scientific Inc.
    • 14.1.14. Wickham Micro Limited
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. MONOCYTE ACTIVATION TESTS MARKET RESEARCH PROCESS
  • FIGURE 2. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. MONOCYTE ACTIVATION TESTS MARKET DYNAMICS
  • FIGURE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
  • FIGURE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MONOCYTE ACTIVATION TESTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MONOCYTE ACTIVATION TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY CELL LINE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PBMC-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICES TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 188. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 189. MONOCYTE ACTIVATION TESTS MARKET LICENSE & PRICING